Skip to main content
. 2009 Feb 17;100(4):578–582. doi: 10.1038/sj.bjc.6604913

Table 2. Breast cancer risk associated with plasma leptin concentrations.

Leptin level (ng ml−1) No. of cases (%) No. of controls (%) Matched ORa (95% CI) Adjusted ORb (95% CI)
All women
 <5.06 68 (22.9) 147 (24.9) 1.00 (reference) 1.00 (reference)
 5.06–10.90 124 (41.8) 299 (50.8) 0.93 (0.63–1.38) 0.87 (0.60–1.26)
 >10.90 105 (35.3) 143 (24.3) 1.63 (1.07–2.49) 1.58 (1.02–2.43)
Ptrend     0.009 0.039
         
Premenopausal
 <4.82 37 (21.5) 83 (25.0) 1.00 (reference) 1.00 (reference)
 4.82–10.60 83 (48.3) 168 (50.6) 1.11 (0.68–1.75) 0.99 (0.61–1.61)
 >10.60 52 (30.2) 81 (24.4) 1.40 (0.83–2.38) 1.63 (0.91–2.89)
Ptrend     0.200 0.103
         
Postmenopausal
 <5.20 28 (22.4) 34 (24.9) 1.00 (reference) 1.00 (reference)
 5.20–11.50 47 (37.6) 131 (50.9) 0.78 (0.44–1.37) 0.71 (0.40–1.26)
 >11.50 50 (40.0) 62 (24.2) 1.69 (0.95–3.06) 1.35 (0.70–2.60)
Ptrend     0.050 0.324

CI=confidence interval; OR=odds ratio.

a

Odds ratios were matched on the date of enrolment and fasting status.

b

In addition to matched variables, odds ratios were also adjusted for body mass index and waist circumference.